DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)

171 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2021.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16,496,810 shares of 834,731,296 outstanding shares and own 1.98% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (3,417,815 shares), RENAISSANCE TECHNOLOGIES LLC (1,914,738 shares), BlackRock Inc. (1,553,550 shares), VANGUARD GROUP INC (1,153,503 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (881,893 shares), STATE STREET CORP (875,479 shares), AMERIPRISE FINANCIAL INC (632,649 shares), DIMENSIONAL FUND ADVISORS LP (581,849 shares), GOLDMAN SACHS GROUP INC (556,640 shares), and Nuveen Asset Management, LLC (443,805 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.